El IIS Aragón participa en un estudio internacional para predecir de forma más precisa el riesgo cardiovascular
10 diciembre, 2025Breakthrough T1D – Common mechanisms in Autoimmunity Insight Awards
10 diciembre, 2025These studies are independent, innovative research studies conceived, designed and supported by qualified researchers, involving both Investigational Use Only (IUO) / Research Use Only (RUO) and post-launch QIAGEN products.
A study protocol shall be submitted to QIAGEN for review by the Medical Affairs staff. Proposals must be submitted in English, and with a detailed description of the study design, objectives and workflow.
Key Evaluation Criteria
- Study is aligned with QIAGEN areas of clinical interest and research goals of evaluating the utility of QIAGEN products to provide additional insights into technical, medical and/or economic value of our products to patients, clinicians, administrators or laboratories
- Is conducted by experienced and qualified researchers
- The study protocol is well designed and scientifically valid, with the intention to result in publication in a peer-reviewed journal within 18 months of initiation
- Provides added value to the current body of knowledge regarding the QIAGEN product of interest
- Ethics committee or institutional review board and/or health authority approval